HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,984,644 | +11.2% | 51,730 | -1.1% | 0.03% | +12.0% |
| Q2 2023 | $5,381,112 | -5.8% | 52,320 | 0.0% | 0.02% | -16.7% |
| Q1 2023 | $5,710,205 | -1.2% | 52,320 | +3.0% | 0.03% | -11.8% |
| Q4 2022 | $5,777,967 | +94.8% | 50,773 | +6.0% | 0.03% | +78.9% |
| Q3 2022 | $2,966,000 | -22.4% | 47,920 | 0.0% | 0.02% | -20.8% |
| Q2 2022 | $3,822,000 | -19.8% | 47,920 | +5.8% | 0.02% | -7.7% |
| Q1 2022 | $4,765,000 | +4.8% | 45,295 | +7.4% | 0.03% | +13.0% |
| Q4 2021 | $4,546,000 | +1.1% | 42,183 | +2.8% | 0.02% | -8.0% |
| Q3 2021 | $4,496,000 | +9.0% | 41,041 | -6.9% | 0.02% | +4.2% |
| Q2 2021 | $4,126,000 | +15.0% | 44,061 | +13.0% | 0.02% | +4.3% |
| Q1 2021 | $3,589,000 | +27.5% | 38,990 | +1.3% | 0.02% | +21.1% |
| Q4 2020 | $2,816,000 | – | 38,490 | – | 0.02% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |